Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Moderna Inc
(NQ:
MRNA
)
82.44
+1.40 (+1.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna Inc
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
10 Health Care Stocks Whale Activity In Today's Session
June 25, 2024
Via
Benzinga
What's Going On With Eli Lilly Stock On Tuesday?
June 25, 2024
Eli Lilly collaborates with Microsoft-backed OpenAI to leverage generative AI for developing novel antimicrobials targeting drug-resistant pathogens. This partnership supports Lilly's commitment to...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Moderna's Options: A Look at What the Big Money is Thinking
June 24, 2024
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $900 Today
June 21, 2024
Via
Benzinga
Market Whales and Their Recent Bets on MRNA Options
June 20, 2024
Via
Benzinga
S&P 500, Nasdaq Lurking Below Record Highs
June 18, 2024
Stocks are scattered this afternoon, as investors digest a weaker-than-expected retail sales reading from May.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Smart Money Is Betting Big In MRNA Options
June 11, 2024
Via
Benzinga
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
June 07, 2024
Via
ACCESSWIRE
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
June 18, 2024
AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a...
Via
Benzinga
Exposures
COVID-19
The RBA Kept Interest Rates On Hold And Remained Hawkish
June 18, 2024
The Reserve Bank of Australia kept the cash rate at 4.35% at its June meeting, leaving borrowing costs unchanged for the fifth time.
Via
Talk Markets
OpenAI And Color Health Develop AI-Driven Cancer Care Solutions: Report
June 17, 2024
OpenAI and startup Color Health have developed an AI assistant, named 'copilot', to support physicians in creating personalized cancer care plans, emphasizing the tool's role in augmenting rather than...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines
June 17, 2024
Biotechnology firm Moderna Inc. (NASDAQ: MRNA) made mainstream headlines during the pandemic for its COVID-19 vaccines. Moderna is focused on messenger RNA
Via
MarketBeat
Exposures
COVID-19
Moderna Just Gave Investors Another Reason to Buy the Stock
June 16, 2024
The company's post-pandemic prospects are getting brighter.
Via
The Motley Fool
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccine
June 13, 2024
Via
ACCESSWIRE
7 Struggling Stocks to Sell Before July 2024
June 12, 2024
The stock market is riding high for now. But even a roaring bull market can't save these seven stocks to sell.
Via
InvestorPlace
3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants
June 11, 2024
After the FDA's authorization of a Covid19 booster shot, you may want to consider adding these vaccine stocks to your portfolio.
Via
InvestorPlace
Exposures
Product Safety
Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
June 10, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
What's Going On With Moderna Stock Monday?
June 10, 2024
Moderna said its Phase 3 trial of mRNA-1083, an investigational combination vaccine against influenza and COVID-19, met its primary endpoints.
Via
Benzinga
Exposures
COVID-19
Nike, Merck, General Motors, And More: CNBC's 'Final Trades'
June 10, 2024
Liz Young of SoFi recommends Energy Select Sector SPDR Fund as her final trade on CNBC's Halftime Report. Jim Lebenthal of Cerity Partners picks General Motors, while Jason Snipe of Odyssey Capital...
Via
Benzinga
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
June 10, 2024
If approved, this would be the first combination vaccine based on mRNA technology to hit the market.
Via
Investor's Business Daily
Exposures
COVID-19
Why Moderna Stock Is a No-Brainer Buy Right Now
June 10, 2024
This messenger-RNA pioneer should be able to keep its rebound going.
Via
The Motley Fool
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
June 10, 2024
Via
ACCESSWIRE
3 Reasons to Buy Moderna Stock
June 08, 2024
The biotech hasn't said its last word.
Via
The Motley Fool
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
June 07, 2024
Moderna has submitted an FDA application for its 2024-2025 Spikevax formula, targeting the prevalent SARS-CoV-2 variant JN.1.
Via
Benzinga
Exposures
COVID-19
Product Safety
5 Stocks Propelling S&P 500 To 25th Record High
June 06, 2024
While most of the stocks have performed well, here are five of them that led the way higher in yesterday's trading session.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Meme Stocks Surge Led by ‘Roaring Kitty’ and Social Media Buzz on Reddit (NYSE: RDDT), GME, DYAI, AMC, PRSO, NVAX
June 06, 2024
Via
AB Newswire
First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map
June 06, 2024
Moderna shares are up almost 29% this month; CureVac is up 72% in the past month; and Novavax spiked 317% in the past month.
Via
Benzinga
Novavax Stock’s Recent Surge and Future Potential
June 06, 2024
Novavax's future hinges on its ability to translate recent stock market momentum into sustained financial performance.
Via
MarketBeat
Topics
Economy
Exposures
COVID-19
Product Safety
Supply Chain
FDA Selects Moderna's Rare Disease Candidate For Accelerated Development Program
June 06, 2024
Moderna's mRNA-370 has been selected for the FDA's START program to accelerate rare disease therapeutics, targeting a 2024 pivotal study.
Via
Benzinga
Exposures
Product Safety
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
June 06, 2024
Novavax will be ready for the new Covid-19 JN.1 variants in September, but NVAX stock is also undergoing a short squeeze.
Via
InvestorPlace
Exposures
COVID-19
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.